On this page
What is Insulin Resistance?
Insulin is a hormone involved in numerous processes throughout the body. While its role in controlling blood sugar (glycemia) is the most widely known, it also influences the metabolism of fats and proteins.
Insulin resistance is the condition in which the body’s cells become less responsive to the signals carried by insulin. It is extremely common. Studies conducted in the United States have found some degree of insulin resistance in more than 30% of the population. Despite its prevalence, it is far from a minor concern: insulin resistance is a key driver of well-recognized and serious conditions, including type 2 diabetes mellitus and polycystic ovary syndrome (PCOS).
What makes insulin resistance particularly insidious is that it develops silently, without obvious symptoms, often going unrecognized for years while quietly contributing to metabolic damage.
What Is Insulin and What Does It Do?
Insulin is a peptide hormone secreted by the beta cells of the pancreas. Its primary role is to regulate the amount of nutrients, particularly glucose or sugar, circulating in the bloodstream.
Here is how the process works under normal conditions:
- After eating a meal containing carbohydrates, blood sugar levels rise as glucose is absorbed from the intestine into the bloodstream.
- In response, the pancreas releases insulin into the blood.
- Insulin travels to cells in muscles, the liver, and fat tissue, signaling them to take up glucose from the blood.
- As cells absorb glucose, blood sugar levels fall back to a safe range.
This mechanism is critically important. Excessively high blood glucose is toxic to cells and tissues, and if left uncorrected, it can cause severe damage. This damage may affect nerves, kidneys, blood vessels, and the eyes.
Beyond glucose control, insulin also influences:
- Protein synthesis and muscle building
- Fat storage and lipid metabolism
- Liver function and glycogen storage
What Happens in Insulin Resistance?
In insulin resistance, cells, particularly in muscle, fat, and liver, stop responding normally to insulin signals. The pancreas compensates by producing increasingly larger amounts of insulin to achieve the same effect. This leads to a state called hyperinsulinemia (abnormally high circulating insulin levels).
Initially, this compensatory mechanism keeps blood sugar in check. However, over time:
- The pancreatic beta cells become exhausted from the chronic overproduction
- Blood insulin levels remain persistently elevated
- Blood glucose levels begin to rise, as cells can no longer adequately absorb it
When blood glucose chronically exceeds a defined threshold, type 2 diabetes is diagnosed. It affects hundreds of millions of people worldwide, and the number of cases continues to grow, driven in part by increasing rates of obesity, physical inactivity, and other lifestyle-related risk factors. Despite this, it remains widely underestimated in terms of its serious health consequences.
Causes
Several factors can contribute to the development of insulin resistance. One of the most underappreciated factors by patients is the role of elevated circulating blood fats, broadly referred to as cholesterol. Multiple studies have demonstrated that fatty acids can directly impair cellular insulin sensitivity.
The rise in blood lipids is primarily driven by caloric overconsumption and excess adipose (fat) tissue.
The Role of Body Fat: Not All Fat Is Equal
While overweight and obesity are among the leading risk factors, not all fat distribution patterns carry the same risk. Fat accumulation patterns vary by genetics and sex:
- Women tend to accumulate fat more on the hips, buttocks, and thighs (gynoid or “pear-shaped” pattern)
- Men more commonly accumulate fat around the abdomen (android or “apple-shaped” pattern)
More importantly, fat can be stored in two fundamentally different locations:
| Type | Location | Metabolic Risk |
|---|---|---|
| Subcutaneous fat | Just beneath the skin | Lower risk |
| Visceral fat | Surrounding internal organs (liver, pancreas, intestines) | High risk |
Visceral fat is the most metabolically dangerous: it releases large amounts of free fatty acids and pro-inflammatory substances directly into the portal circulation, actively promoting insulin resistance in the liver and peripheral tissues.
Other Contributing Causes
Importantly, insulin resistance can also develop in normal-weight or even underweight individuals. Other significant causes include:
- High fructose intake from added sugars, particularly from sugar-sweetened beverages and processed foods. Note: fructose from whole fruit is associated with better glycemic control, not worse.
- Chronic low-grade inflammation: systemic inflammation impairs insulin receptor signaling.
- Physical inactivity: exercise directly enhances cellular insulin sensitivity, while sedentary behavior has the opposite effect.
- Gut microbiome dysbiosis: the trillions of bacteria inhabiting the intestine play an important metabolic role. Disruption of this ecosystem (through poor diet, antibiotics, or other factors) can contribute to insulin resistance.
- Genetic factors: Certain ethnic groups, including African, Hispanic, and Asian populations, carry a higher genetic susceptibility to insulin resistance.
Symptoms
One of the most challenging aspects of insulin resistance is that it typically causes no noticeable symptoms. Its course is silent and gradual, which is why it often goes undetected until significant metabolic damage has already occurred.
In some cases, patients with pronounced hyperinsulinemia may develop acanthosis nigricans, which is a darkening and thickening of the skin in body folds such as the neck, armpits, and groin. This is considered a visible marker of insulin resistance and is more commonly observed in children and adolescents.
Other non-specific signs that may prompt investigation include:
- Persistent fatigue, especially after meals
- Difficulty losing weight despite caloric restriction
- Intense hunger or sugar cravings shortly after eating
- Mental “brain fog” or difficulty concentrating
- Abdominal weight gain
However, none of these signs are specific to insulin resistance, and the condition is most reliably identified through laboratory testing.
Complications and Related Conditions
Despite its silent nature, insulin resistance has serious long-term consequences. It serves as a common thread linking several major chronic diseases:
Metabolic Syndrome
Insulin resistance serves as the core characteristic of metabolic syndrome, which is a group of coexisting risk factors. This combination significantly raises the chances of developing diabetes, cardiovascular disease, and other serious health conditions. For more details, you can explore the topic here. Diagnostic criteria include:
- High blood pressure (hypertension)
- Elevated fasting blood glucose
- High triglycerides
- Low HDL (“good”) cholesterol
- Central obesity (increased waist circumference)
Type 2 Diabetes
This is the most well-known complication of insulin resistance. Over time, when the pancreas can no longer produce enough insulin to compensate for cellular resistance, blood glucose levels rise chronically. This eventually leads to a formal diagnosis of type 2 diabetes. Notably, the progression from insulin resistance to type 2 diabetes also involves progressive loss of pancreatic beta-cell function.
Cardiovascular Disease
Insulin resistance and metabolic syndrome have a strong connection to cardiovascular disease, which is the leading cause of death worldwide. For more details, you can read about myocardial infarction here. People with insulin resistance or metabolic syndrome have approximately 93% higher risk of developing cardiovascular events (including stroke and heart attack) compared to healthy individuals.
Other Associated Conditions
Research has also identified associations between insulin resistance and:
- Non-alcoholic fatty liver disease (NAFLD): Abnormal fat accumulation in the liver unrelated to alcohol consumption
- Polycystic ovary syndrome (PCOS): Insulin resistance plays a key pathophysiological role in many women with PCOS, driving androgen excess and menstrual irregularities
- Alzheimer’s disease: Some researchers refer to Alzheimer’s as “type 3 diabetes”, reflecting the growing evidence of links between impaired insulin signaling in the brain and neurodegeneration
- Certain cancers: Hyperinsulinemia and related growth factors may promote tumor growth in several cancer types
Diagnosis
Because insulin resistance causes no symptoms, diagnosis often occurs incidentally. This may happen during laboratory investigations ordered for other reasons, such as infertility or suspected PCOS. Alternatively, a physician might identify known risk factors like elevated BMI, central fat distribution, or abnormal blood lipid levels.
Several diagnostic methods are available. The following are the most used in clinical practice:
1. Oral Glucose Tolerance Test (OGTT)
The patient drinks a standardized solution of water and glucose (typically 75 g). Blood glucose is then measured at fasting and 2 hours after ingestion.
| Result | Interpretation |
|---|---|
| Fasting glucose < 100 mg/dL and 2-hour glucose < 140 mg/dL | Normal |
| Fasting glucose 100–125 mg/dL or 2-hour glucose 140–199 mg/dL | Prediabetes / Impaired glucose tolerance |
| Fasting glucose ≥ 126 mg/dL or 2-hour glucose ≥ 200 mg/dL | Type 2 Diabetes |
2. HOMA-IR Index
The HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a mathematical index calculated from fasting blood glucose and fasting insulin levels:
HOMA-IR = (Fasting Insulin [mU/L] × Fasting Glucose [mmol/L]) ÷ 22.5
A HOMA-IR value above 2.5–3.0 (depending on the laboratory reference range) is generally considered indicative of significant insulin resistance. This test is simple, inexpensive, and widely used in both clinical practice and research.
3. Fasting Insulin Measurement
Fasting hyperinsulinemia (abnormally high insulin levels before eating) is a reliable marker of reduced cellular insulin sensitivity. When blood glucose remains normal but insulin levels are significantly elevated, the pancreas is already working overtime to maintain glycemic control. This is a clear early warning sign.
4. HbA1c (Glycated Hemoglobin)
While primarily used to diagnose and monitor diabetes, HbA1c provides information about average blood glucose levels over the preceding 2–3 months and can help identify prediabetes in patients with insulin resistance.
Diet and Other Remedies
The encouraging news is that insulin resistance is largely reversible through lifestyle modifications. Multiple studies have shown that targeted changes, even without pharmacological treatment, can significantly improve insulin sensitivity. In many cases, these changes can even lead to complete resolution of the condition.
Physical Activity
Regular exercise is arguably the single most powerful tool for improving insulin sensitivity. Both aerobic exercise, such as walking, cycling, or swimming, and resistance training, like weightlifting, stimulate glucose uptake by muscle cells independently of insulin. This effect starts almost immediately after a single session and builds up with regular practice.
Current guidelines recommend:
- At least 150 minutes per week of moderate-intensity aerobic activity
- 2 or more sessions per week of resistance training
Even breaking up prolonged sitting with short walking breaks has been shown to improve glycemic control.
Weight Loss
For individuals who are overweight, particularly those with central or abdominal adiposity, combining diet and exercise for weight loss is one of the most effective interventions. You can find more details here. Even a 5–10% reduction in body weight can produce meaningful improvements in insulin sensitivity and reduce cardiovascular risk factors.
Dietary Improvements
No single “insulin resistance diet” fits all patients, but evidence consistently supports the following principles:
- Reduce added sugars and refined carbohydrates: Sugary beverages, white bread, pastries, and processed snacks cause rapid blood glucose and insulin spikes. Replace them with whole grain alternatives and fiber-rich foods that slow glucose absorption.
- Increase dietary fiber: Vegetables, legumes, whole grains, and fruits support gut microbiome health and slow glucose absorption.
- Choose healthy fats: Increase consumption of omega-3 fatty acids. These fats, found in oily fish like salmon, sardines, and mackerel, as well as seeds such as flaxseed, chia, and hemp, directly reduce triglyceride levels and have anti-inflammatory effects.
- Prioritize plant-based foods: Diets rich in vegetables, legumes, nuts, and whole grains, such as the Mediterranean diet, are consistently linked to improved insulin sensitivity.
- Limit ultra-processed foods: These are high in refined carbohydrates, added sugars, unhealthy fats, and artificial additives that promote inflammation and dysbiosis.
Quit Smoking
Smoking is an independent risk factor for insulin resistance and type 2 diabetes. The chemicals in tobacco smoke promote oxidative stress and inflammation, impairing insulin signaling. Quitting smoking improves insulin sensitivity and reduces cardiovascular risk.
Improve Sleep Quality and Duration
Insufficient or poor-quality sleep significantly impairs insulin sensitivity and glucose metabolism. Even one night of sleep deprivation can produce measurable insulin resistance the following day. Targeting 7–9 hours of quality sleep per night is an important and often overlooked component of metabolic health.
Manage Chronic Stress
Chronic stress elevates cortisol levels, which counteract insulin and promote blood glucose elevation and fat storage (particularly visceral fat). Stress management techniques with evidence of benefit include:
- Mindfulness meditation
- Diaphragmatic breathing exercises
- Yoga
- Regular nature walks
Blood Donation (in Selected Cases)
In patients with elevated iron levels, which have been linked to insulin resistance, regular blood donation can help reduce excess iron stores. This practice may also contribute to improved metabolic parameters. This should only be considered when iron levels are confirmed as elevated.
Intermittent Fasting
Intermittent fasting, a dietary approach involving structured periods of eating and fasting (such as a 16-hour fast followed by an 8-hour eating window or the 5:2 protocol), has gained increasing scientific support. Research shows it can improve insulin sensitivity, reduce fasting insulin levels, and promote weight loss. It is not suitable for everyone and should only be attempted under the supervision of a qualified healthcare professional.
Important: The strategies listed above represent the main evidence-based interventions with a positive impact on insulin resistance and overall health. However, it is essential to consult your doctor before making significant changes to your lifestyle, diet, or supplement regimen. This is especially important to evaluate the best options based on your individual health status, any coexisting conditions, and current medications.
Sources and Bibliography
- Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiological Reviews. 2018;98(4):2133–2223. DOI: 10.1152/physrev.00063.2017
- American Diabetes Association. Standards of Medical Care in Diabetes – 2024. Diabetes Care. 2024;47(Supplement_1). diabetesjournals.org
- Warram JH, et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Annals of Internal Medicine. 1990;113(12):909–15.
- Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Medicine. 2017;15(1):131. DOI: 10.1186/s12916-017-0901-x
- Lim SS, et al. Fructose in fruit vs added sugars and glycemic control Journal of Clinical Endocrinology & Metabolism. 2021;106(10):e4097. DOI: 10.1210/clinem/dgab358
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Insulin Resistance & Prediabetes
- Mayo Clinic. Insulin resistance: What is it?
- Grundy SM, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52. DOI: 10.1161/CIRCULATIONAHA.105.169404
